Home > Income Statement > BETA DRUGS
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹42 Cr₹36 Cr₹31 Cr₹25 Cr₹12 Cr

What is the latest Consolidated Net Profit of BETA DRUGS ?

The latest Consolidated Net Profit ratio of BETA DRUGS is ₹42 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹42 Cr
Mar2024₹36 Cr
Mar2023₹31 Cr
Mar2022₹25 Cr
Mar2021₹12 Cr

How is Consolidated Net Profit of BETA DRUGS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹42 Cr
16.42
Mar2024 ₹36 Cr
18.61
Mar2023 ₹31 Cr
23.73
Mar2022 ₹25 Cr
111.75
Mar2021 ₹12 Cr -

Compare Consolidated Net Profit of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,606.1 Cr 13.5% 59.1% 35.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,644.0 Cr 1.1% 7.2% 15.4% Stock Analytics
DIVIS LABORATORIES ₹184,053.0 Cr 2.4% 4.2% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹167,464.0 Cr 1.9% 8.3% 45.6% Stock Analytics
CIPLA ₹115,263.0 Cr -1.8% 3.2% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,049.0 Cr -8.8% -3.2% -4.6% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

13.5%

59.1%

35.7%

SENSEX

-0.9%

4.9%

-6.8%


You may also like the below Video Courses